InvestSMART

Medibank Private Limited (ASX:MPL)

ALERT: Price-sensitive ASX Announcement for MPL
Current share price for MPL : $5.040 0.25 (5.22%)+
Release
19 Feb 2026 7:41AM
Price at Release
$4.790
Full Release
download
Summary
Medibank Private Limited's HY26 results showcase a solid financial performance with a group operating profit increase of 6.0%. The company reported a 4.3% growth in premium revenue, driven by both resident and non-resident health insurance segments. Medibank Health segment profit rose significantly by 28.5%, reflecting the company's strategic investments in health services and customer engagement initiatives such as the Live Better rewards program. Despite challenges like increased corporate overheads due to inflation and a decrease in net investment income, Medibank maintained its operating margin. There was a slight decline in net profit after tax attributable to shareholders. The company also faced non-recurring cybercrime costs, but it remains focused on enhancing IT security. Medibank continues to prioritize policyholder growth, retention, and product differentiation, aiming for further expansion in the second half of FY26.
Key Points
  • Group operating profit increased by 6.0%.
  • Premium revenue grew by 4.3%.
  • Medibank Health segment profit increased by 28.5%.
  • Net investment income decreased by 17.1%.
  • Non-recurring cybercrime costs impacted profit.
  • Continued focus on IT security enhancements.
  • Policyholder growth and product differentiation remain priorities.
  • Dividend per share increased to 8.3 cents.
  • Medibank aims for further expansion in 2H26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.